OMKARCHEM

Omkar Speciality Chemicals Limited has informed the Exchange that Omkar Speciality Chemicals Limited (OSCL), a manufacturer of Speciality Chemicals, Intermediates and Active Pharmaceuticals Ingredients (APIs), has filed one more application for the grant of Patent for preparing 4-BROMO-ORTHO-PHENYLENE-DIAMINE, a key precursor for making of the drug namely Ledipasvir. Ledipasvir is a drug for the treatment of Hepatitis C.

Omkar Speciality Chemicals Limited has submitted to the Exchange a copy of revised Financial Results (Standalone and Consolidated) for the financial year ended on March 31, 2015.

Omkar Speciality Chemicals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Mar-2015.

Omkar Speciality Chemicals Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on May 18, 2015 has approved the following :(1) The Board of Directors has recommended for formulating the scheme of Employee Stock Option Plan (ESOP) named as OSCL ESOP 2015 , subject to the approvals of the concerned regulatory authorities and the members of the Company. (2). Constitution/Reconstitution of the various committees of the Board of Directors.

Omkar Speciality Chemicals Limited has informed the Exchange that the Board of Directors at its meeting held on May 18, 2015 has approved the following: (1). Pursuant to the requirements of Regulation 8 of SEBI (Prohibition of Insider Trading) Regulation, 2015, the Company have formulated and published on its website www.omkarchemicals.com, the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information", a copy of which is enclosed herewith for your record. (4). Pursuant to the requirements of Regulation 9 of SEBI (Prohibition of Insider Trading) Regulatio

Omkar Speciality Chemicals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 18, 2015 has recommended a dividend of Rs. 1.50 (15%) per Equity Share of Rs. 10 each for the Financial Year ended on March 31, 2015.

Omkar Speciality Chemicals Limited has informed the Exchange that Mr. Pravin S. Herlekar, Promoter and Chairman & Managing Director of OSCL has been honored for his dedicated services to the Chemical Industry and developing various molecules through research and development activity in this field, by Free Press Journal group, at the hands of Mr. Devendra Fadnavis, Chief Minister of State of Maharashtra, in the presence of Hon'ble Shri Ram Naik, Governor of State of Uttar Pradesh, on April 30, 2015.

Omkar Speciality Chemicals Limited has informed the Exchange that as per SEBI (Prohibition of Insider Trading Regulation), 1992 and the Code of Conduct adopted by the Company, the 'Trading Window' for trading in the Company's securities shall remain closed for the Promoters, Directors and Designated Employees of the Company from May 9, 2015 till May 19, 2015 (both days Inclusive) for the purpose of declaration of Audited Financial Results and declaration of dividend, if any.

Omkar Speciality Chemicals Limited has informed the Exchange that the Board meeting of the Company was held on May 08, 2015. The following are some of the important items of agenda which were discussed and approved at the meeting: 1) Considered and approved appointment of Mr. Sitendu Sharma as an Additional Director in the capacity of Independent Director of the Company, w.e.f. May 8, 2015; 2) Reconstitution of the committees of Board of Directors; 3) Discussion of other matters as per the agenda of the meeting.

Omkar Speciality Chemicals Limited has informed the Exchange regarding Company's bags concrete indents worth Rs. 100 crore.

Omkar P. Herlekar has submitted to the Exchange vide letter dated April 06, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

P. S. Herlekar has submitted to the Exchange vide letter dated April 06, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Omkar Speciality Chemicals Limited has informed the Exchange regarding the outcome of the Board meeting of the Company held on March 26, 2015. The following are some of the important items of agenda which were discussed and approved at the meeting; 1) Considered and took note of the Resignation tendered by Mr. Amit A. Pandit, Independent Director and Chairman of Audit Committee of the Company, w.e.f. March 26, 2015; 2) Considered and took note of the Resignation tendered by Mr. Siddharth S. Sinkar, Non-Executive and Non-Independent Director of the Company, w.e.f. March 26, 2015; 3) Consid

Omkar Speciality Chemicals Limited has informed the Exchange that the Board of Directors of the Company has approved the appointment of and designated, Mr. Hiral Patel, as Chief Financial Officer of the Company, by passing the circular resolution dated March 18, 2015. The said appointment is made for the period of one year with effect from March 18, 2015 expiring on March 17, 2016 on such remuneration, terms & conditions, as may be determined by the Board of Directors from time to time.

Omkar Speciality Chemicals Limited has informed the Exchange that regarding Commissioning of the Unit No VI, located at Plot No.B-15 & B-15, Lote Parshuram MIDC, Chiplun, Dist : Ratnagiri, State: Maharashtra.

Omkar Speciality Chemicals Limited has informed the Exchange regarding the Outcome of the Board Meeting of the Company held on February 2, 2015.

Omkar Speciality Chemicals Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 31-Dec-2014.

Omkar Speciality Chemicals Limited has informed the Exchange that the Trading Window for trading in the Company s securities shall remain closed for the Promoters, Directors and Designated Employees of the Company from January 24, 2015 till February 03, 2015 (both days inclusive) for the purpose of declaration of quarterly financial results.

IDBI Trusteeship Services Ltd has submitted to the Exchange vide letter dated January 15, 2015 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Ambit Finvest Private Limited has submitted to the Exchange vide letter dated January 14, 2015 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Omkar Speciality Chemicals Limited has submitted to the Exchange vide letter dated December 24, 2014 a copy of Declaration of results of Voting - Special Resolutions proposed vide Postal Ballot Notice dated November 13, 2014 alongwith Report of Scrutinizer. (Revised)

Omkar Speciality Chemicals Limited has submitted to the Exchange vide letter dated December 24, 2014 a copy of Declaration of results of Voting - Special Resolutions proposed vide Postal Ballot Notice dated November 13, 2014 and Report of Scrutinizer.

Omkar Speciality Chemicals Limited has submitted to the Exchange vide letter dated December 15, 2014 a copy of disclosure under Regulation 13(4), 13(4A), 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Omkar Speciality Chemicals Limited has submitted to the Exchange vide letter dated December 05, 2014 a copy of disclosure under Regulation 13 of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Omkar Speciality Chemicals Limited has submitted to the Exchange, vide letter dated December 4, 2014 a copy of Disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulation,1992.

Omkar Speciality Chemicals Limited has submitted to the Exchange vide letter dated November 24, 2014 a copy of disclosure under Regulation 13 of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Omkar Speciality Chemicals Limited has submitted to the Exchange, vide letter dated November 22, 2014 a copy of Disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulation,1992.

Omkar Speciality Chemicals Limited has submitted to the Exchange a copy of postal ballot notice to seek consent of the members by passing of following special resolutions through postal ballot: 1)Increase in the Authorised Capital of the Company from Rs. 25 crores to Rs. 35 crores and consequent amendment in capital clause of the Memorandum of Association of the Company 2)To authorize the Board of Directors to raise funds through issue of Equity Shares through Qualified Institutions Placement (QIP) of an amount not exceeding Rs. 125 crores.

Omkar Speciality Chemicals Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Sep-2014.

Omkar Speciality Chemicals Limited has informed the Exchange that in the Board meeting of the Company held on November 13, 2014, the Board discussed and approved following - 1) Raising of funds upto an amount of Rs. 125 crores, by way of a qualified institutions placement, on such terms and conditions as may be decided by the Board of Directors and / or Committee of the Board, in accordance with the provisions of Chapter VIII of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 and other applicable laws, subject to approval of the members

Omkar Speciality Chemicals Limited has informed the Exchange that as per SEBI (Prohibition of Insider Trading Regulation), 1992 and the Code of Conduct adopted by the Company, the 'Trading Window' for trading in the Company's securities shall remain closed for the Promoters, Directors and Designated Employees of the Company from November 05, 2014 till November 14, 2014 (both days Inclusive) for the purpose of declaration of quarterly financial results.

Omkar Speciality Chemicals Limited has informed the Exchange that Company's claim for process patent for an Advance Intermediate namely "BENZENESELENINIC ANHYDRIDE" , having special applications in pharmaceutical industry has been accepted by the Patents Office, Govt. of India. A copy of the Certificate is enclosed herewith.

Omkar Speciality Chemicals Limited has submitted to the Exchange, vide letter dated October 28, 2014 a copy of Disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulation,1992.

Omkar Speciality Chemicals Limited has informed the Exchange that the wholly owned subsidiary, M/s. Lasa Laboratory Private Limited, has been successful in obtaining the Certificate of Suitability from European Directorate for the Quality of Medicines & Healthcare (EDQM), vide certificate No. R0-CEP 2013-184-Rev 00 dated 15th October, 2014, for selling its product FENBENDAZOLE . This certificate will be useful for the Company in marketing its above product to regulatory customers in the European Market for Veterinary use.

Omkar Speciality Chemicals Limited has informed the Exchange that Company is pleased to invite the Shareholders of the Company, to visit its Plants located in the vicinity of Badlapur on November 1, 2014. This Plant visit is a half day program and is limited for 100 people. Shareholders who are interested can make reservation by sending an email at investor@omkarchemicals.com on or before October 20, 2014.

Omkar Speciality Chemicals Limited has submitted to the Exchange, vide letter dated October 06, 2014 a copy of Disclosure under Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulation,1992.

Omkar Speciality Chemicals Limited has informed the Exchange that the Company's claim for process patent for an Advance Intermediate namely "5-IODO-2-METHYLBENZOIC ACID", having special applications in pharmaceutical industry has been accepted by the Patents Office, Govt. of India, vide their Certificate dated September 10, 2014.

SBI Funds Management Private Limited has submitted to the Exchange, vide letter dated September 05, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Omkar Speciality Chemicals Limited has submitted to the Exchange, vide letter dated September 06, 2014 a copy of disclosure under regulation 29 of SEBI (Substantial Acquisition of shares and take overs) Regulation 2011 along with a copy of Disclosure under Regulation 13 of SEBI (Prohibition of Insider Trading) Regulation,1992.

Omkar Speciality Chemicals Limited has informed the Exchange regarding declaration of results of Voting - Special Resolutions proposed vide Postal Ballot Notice dated June 20, 2014.

Omkar Speciality Chemicals Limited has informed the Exchange that the Board of Directors have granted their approval for issuance of 950000 Equity Shares of Rs. 10 each fully paid-up at a price Rs. 150 per share to the promoters and promoter group, pursuant to the conversion of Warrants issued by the Company, in accordance with the Securities and Exchange Board of India (Issue of capital and Disclosure Requirement ) Regulations, 2009 [ SEBI (ICDR) Regulations ] as amended from time to time.

Ambit Finvest Private Limited has submitted to the Exchange, vide letter dated August 26, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Ambit Finvest Private Limited has submitted to the Exchange vide letter dated August 20, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Omkar Speciality Chemicals Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Jun-2014.

Omkar Speciality Chemicals Limited has informed the Exchange regarding the Proceedings of the AGM of the Company held on August 9, 2014.

Omkar Speciality Chemicals Limited has submitted to the Exchange a copy of Postal Ballot Notice pursuant to Sections 2(65) and 110 of the Companies Act, 2013 alongwith the Postal Ballot Form.

SBI Funds Management Private Ltd has submitted to the Exchange vide letter dated July 16, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Omkar Speciality Chemicals Limited has submitted to the Exchange vide letter dated July 17, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Omkar Speciality Chemicals Limited has informed the Exchange that all business set out in the Notice of Annual General Meeting may be transacted by Electronic Voting. The e-voting period commences on August 03, 2014 and ends on August 05, 2014.

Omkar Speciality Chemicals Limited has informed the Exchange that the Annual General Meeting of the Company will be held on August 09, 2014. Further, the Register of Members and Share Transfer Books of the Company will remain closed from August 02, 2014 to August 09, 2014( both days inclusive) for the purpose of declaration of dividend.